This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08279/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08279/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB08279/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08279/identifier/drugbank/

Statements

Subject Item
n2:DB08279
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n12:DB08279 n13:DB08279
dcterms:title
3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID
adms:identifier
n4:503536 n5:99444750 n8:DB08279 n9:NN3
n6:IUPAC-Name
n7:271B48B0-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B48B6-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B48B5-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B48B2-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B48B3-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B48B4-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B48AE-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B48AC-363D-11E5-9242-09173F13E4C5 n7:271B48AF-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B48AD-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B48BC-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B48BD-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B48B7-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B48B8-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B48BA-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B48B9-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B48BB-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B48C2-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B48C4-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B48C5-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B48C1-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B48C0-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B48C3-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B48B1-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B48BE-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B48BF-363D-11E5-9242-09173F13E4C5